Prof Isabelle Ray-Coquard (Université Claude Bernard Lyon, Lyon, France), Prof Ignace Vergote (Katholieke Universiteit, Leuven, Belgium), Prof Christian Marth (Innsbruck Medical University, Innsbruck, Austria) and Prof David Cibula (Charles University and General University Hospital, Prague, Czech Republic) discuss the latest in advanced endometrial cancer from ESMO, ESGO and IGCS 2021.

In this expert panel discussion, they talk about how to decide the best treatment for each patient, recent updates to endometrial cancer guidelines, and adverse event management in advanced endometrial cancer.

The panel also discusses mismatch repair deficient (dMMR) patients and sub-populations and histological subtypes of advanced endometrial cancer. They conclude by touching on new options and mentioning what the future holds for endometrial cancer treatment.

ecancer's filming has been kindly supported by Eisai through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.